- 专利标题: Manufacturing method of an herbal medicinal tablet formulation for treating obesity which can be prescribed based on sasang constitutional medicine
-
申请号: US16957432申请日: 2018-12-20
-
公开(公告)号: US11484514B2公开(公告)日: 2022-11-01
- 发明人: Young Woo Lim , Ji Myeong Ok , Woon Ho Lee , Young Bin Kim
- 申请人: NUBEBE CO., LTD. , HUMAN HERB CO., LTD.
- 申请人地址: KR Seongnam-si; KR Daegu
- 专利权人: NUBEBE CO., LTD.,HUMAN HERB CO., LTD.
- 当前专利权人: NUBEBE CO., LTD.,HUMAN HERB CO., LTD.
- 当前专利权人地址: KR Seongnam-si; KR Daegu
- 代理机构: Lex IP Meister, PLLC
- 优先权: KR10-2017-0183328 20171229,KR10-2018-0143446 20181120
- 国际申请: PCT/KR2018/016341 WO 20181220
- 国际公布: WO2019/132416 WO 20190704
- 主分类号: A61P3/04
- IPC分类号: A61P3/04 ; A61K36/346 ; A61K36/488 ; A61K36/882 ; A61K36/49 ; A61K36/8994 ; A61K36/31 ; A61K36/736 ; A61K36/8945 ; A61K36/185 ; A61K47/02 ; A61K47/46 ; A61K36/534 ; A61K36/744 ; A61K36/538 ; A61K36/708 ; A61K33/04 ; A61K36/64 ; A61K36/65 ; A61K31/137 ; A61K9/19 ; A61K36/258 ; A61K36/481 ; A61K36/284 ; A61K36/54 ; A61K36/9068 ; A61K36/076 ; A61K36/752 ; A61K36/725 ; A61K36/734 ; A61K36/575 ; A61K36/884 ; A61J3/06 ; A61K9/28 ; A61K36/17 ; A61K36/62
摘要:
An embodiment of the present invention provides a manufacturing method of an herbal medicinal tablet formulation for treating obesity which is prescribed based on Sasang constitutional medicine, comprises manufacturing a concentrated ephedra powder agent so that an ephedrine content is 3.0-4.0%; determining a weight of the concentrated ephedra powder agent according to each constitution of Sasang constitutional medicine, and manufacturing a side effect-preventing powder agent for each constitution to prevent and suppress side effects according to constitution of Sasang constitutional medicine with respect to the weight of the concentrated ephedra powder agent; mixing the concentrated ephedra powder agent and the side effect-preventing powder agent with a variance of a weight ratio therebetween in consideration of weight, obesity, constitution of Sasang constitutional medicine, and side effects; and tableting the mixture of the prepared ephedra powder agent and side effect-preventing powder agent.